[P] Poster (3. Parasites)

[P080] Amprenavir as a potential therapeutic candidate for HIV–Leishmaniasis co-infections, acting through Leishmania donovani Topoisomerase I inhibition and oxidative stress-mediated programmed cell death

○Sachidananda Behera^1,2,4, Amit Roy^3,4, Parool Gupta^1,2, Vahab Ali^1,4 (1. Department of Biochemistry, ICMR-Rajendra Memorial Research Institute of Medical Sciences (RMRIMS), Patna (India), 2. Department of Pharmacy, AISECT University, Hazaribagh, Jharkhand-825313, India (India), 3. Department of Biotechnology, Savitribai Phule Pune University, Pune-411007, Maharastra (India), 4. Department of Biotechnology, National Institute of Pharmaceutical Education and Research, NIPER, Hajipur (India))

閲覧にはパスワードが必要です